Beckman Daniella
Insider CIK 1513422 · IDIX SVP, CFO and Treasurer · BPMC Director · TBIO Director · VOR Director · TNGX Chief Financial Officer · FVAM Director · UPB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 53,283 | — | $0 | 53,283 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 17,096 | — | $0 | 17,096 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-04 | 113 | $12.90 | $1.5K | 184,297 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-04 | 10,204 | $12.26 | $125.1K | 184,410 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 265,980 | — | $0 | 265,980 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 44,330 | — | $0 | 194,614 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 10,842 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 10,842 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 14,744 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 17,096 | — | $0 | 17,096 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-06 | 3,948 | $3.16 | $12.5K | 150,284 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2025-02-04 | 2025-02-06 | 4,284 | $2.99 | $12.8K | 154,232 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 156,713 | — | $0 | 156,713 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2025-02-03 | 2025-02-05 | 26,119 | — | $0 | 158,516 | SEC↗ |
| UPB Upstream Bio, Inc. | A Award deriv | 2024-10-10 | 2024-10-15 | 34,681 | — | $0 | 34,681 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 10,842 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-02-07 | 2024-02-08 | 1,817 | $12.62 | $22.9K | 132,397 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-02-06 | 2024-02-08 | 1,908 | $12.56 | $24.0K | 134,214 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 236,475 | — | $0 | 236,475 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2024-02-01 | 2024-02-05 | 39,413 | — | $0 | 39,413 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 8,600 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 197,051 | — | $0 | 197,051 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-02 | 32,842 | — | $0 | 96,709 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-21 | 2022-06-30 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-21 | 2022-06-30 | 2,600 | — | $0 | 6,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-12-08 | 2022-03-31 | 7,000 | — | $0 | 7,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-12-08 | 2022-03-31 | 3,400 | — | $0 | 3,400 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 20,000 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 18,900 | — | $0 | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale deriv | 2021-09-14 | 2021-09-14 | 67,995 | — | $0 | 0 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2021-08-12 | 2021-08-16 | 380,485 | — | $0 | 380,485 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2021-06-16 | 2021-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 16,900 | — | $0 | 16,900 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-10-16 | 2020-10-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2020-06-16 | 2020-06-17 | 18,900 | — | $0 | 18,900 | SEC↗ |
| TBIO Translate Bio, Inc. | A Award deriv | 2019-06-18 | 2019-06-19 | 18,900 | — | $0 | 18,900 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 30,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 50,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 100,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 7,500 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 6,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 15,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-02-10 | 2014-02-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-02-20 | 2013-02-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-02-29 | 2012-03-02 | 100,000 | — | $0 | 100,000 | SEC↗ |